title: Practice parameter for the diagnosis and management of primary immunodeficiency.
abstract: The American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI) have jointly accepted responsibility for establishing the "Practice parameter for the diagnosis and management of primary immunodeficiency." This is a complete and comprehensive document at the current time. The medical environment is a changing environment, and not all recommendations will be appropriate for all patients. Because this document incorporated the efforts of many participants, no single individual, including those who served on the Joint Task Force, is authorized to provide an official AAAAI or ACAAI interpretation of these practice parameters. Any request for information about or an interpretation of these practice parameters by the AAAAI or ACAAI should be directed to the Executive Offices of the AAAAI, the ACAAI, and the Joint Council of Allergy, Asthma & Immunology. These parameters are not designed for use by pharmaceutical companies in drug promotion.
authors.forename: Francisco A
authors.initials: FA
authors.lastname: Bonilla
authors.forename: David A
authors.initials: DA
authors.lastname: Khan
authors.forename: Zuhair K
authors.initials: ZK
authors.lastname: Ballas
authors.forename: Javier
authors.initials: J
authors.lastname: Chinen
authors.forename: Michael M
authors.initials: MM
authors.lastname: Frank
authors.forename: Joyce T
authors.initials: JT
authors.lastname: Hsu
authors.forename: Michael
authors.initials: M
authors.lastname: Keller
authors.forename: Lisa J
authors.initials: LJ
authors.lastname: Kobrynski
authors.forename: Hirsh D
authors.initials: HD
authors.lastname: Komarow
authors.forename: Bruce
authors.initials: B
authors.lastname: Mazer
authors.forename: Robert P
authors.initials: RP
authors.lastname: Nelson
authors.forename: Jordan S
authors.initials: JS
authors.lastname: Orange
authors.forename: John M
authors.initials: JM
authors.lastname: Routes
authors.forename: William T
authors.initials: WT
authors.lastname: Shearer
authors.forename: Ricardo U
authors.initials: RU
authors.lastname: Sorensen
authors.forename: James W
authors.initials: JW
authors.lastname: Verbsky
authors.forename: David I
authors.initials: DI
authors.lastname: Bernstein
authors.forename: Joann
authors.initials: J
authors.lastname: Blessing-Moore
authors.forename: David
authors.initials: D
authors.lastname: Lang
authors.forename: Richard A
authors.initials: RA
authors.lastname: Nicklas
authors.forename: John
authors.initials: J
authors.lastname: Oppenheimer
authors.forename: Jay M
authors.initials: JM
authors.lastname: Portnoy
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Randolph
authors.forename: Diane
authors.initials: D
authors.lastname: Schuller
authors.forename: Sheldon L
authors.initials: SL
authors.lastname: Spector
authors.forename: Stephen
authors.initials: S
authors.lastname: Tilles
authors.forename: Dana
authors.initials: D
authors.lastname: Wallace
mesh_terms: D026683:Advisory Committees; D000818:Animals; D002986:Clinical Trials as Topic; D019468:Disease Management; D019317:Evidence-Based Medicine; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000175:diagnosis* / Q000628:therapy*